IPP Bureau
Zydus receives USFDA approval for Isosorbide Mononitrate Extended-Release, Tablets USP
By IPP Bureau - February 17, 2024
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
Internal restructuring of foreign subsidiaries at Bliss GVS Pharma
By IPP Bureau - February 17, 2024
The restructuring aims to create synergies across the business and strengthen capital structure
YS Biopharma appoints new Directors
By IPP Bureau - February 17, 2024
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Ginkgo, SaponiQx to discover and manufacture next-gen vaccine adjuvants
By IPP Bureau - February 17, 2024
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
Blacksmith Medicines and Zoetis collaborate for novel animal health antibiotics
By IPP Bureau - February 17, 2024
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Glenmark Pharma posts Q3 FY24 net loss of Rs. 331 Cr
By IPP Bureau - February 16, 2024
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
Marksans Q3 FY24 revenue up 22% at Rs 586 Cr
By IPP Bureau - February 16, 2024
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
Lupin launches Ganirelix Acetate Injection in US
By IPP Bureau - February 16, 2024
It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation
Healthcare Triangle unveils new SaaS Solutions to drive AI integration in healthcare
By IPP Bureau - February 16, 2024
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
Medanta launches monthly talk show around cardiac care - 'Heart 2 Heart'
By IPP Bureau - February 15, 2024
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
Mankind Pharma tie-ups with Lepra Society to establish CDCC Centres to screen 80,000 individuals
By IPP Bureau - February 15, 2024
The CDCCs are strategically positioned in regions identified as high-impact areas
UBE announces Phase I clinical trial for SSAO/VAP-1 licensed exclusively to Novo Nordisk
By IPP Bureau - February 15, 2024
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
Ashland launches iSolve information on demand for F&B customers
By IPP Bureau - February 15, 2024
iSolveSM information on demand is the result of our focus on customer relationship
Aparna Group forays into pharma business; Receives USFDA clearance for manufacturing unit
By IPP Bureau - February 15, 2024
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Ascentage Pharma’s Phase III study of Olverembatinib cleared by FDA
By IPP Bureau - February 14, 2024
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
